Trends in Clinical Characteristics and Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013-2018

Citation
Dave CV, Schneeweis S, Wexler DJ, et al. Diabetes Care 2020;43:921–4.